Regulatory sandbox programs lead the digital health innovation pathways market with a 44.2% share in 2026, followed by chronic disease management at 37.9%. Market adoption depends on regulatory guidance, clinical evidence generation, and reimbursement readiness, while implementation capacity and provider acceptance remain critical for broader commercialization.